Jacob Vincent Micallef - 14 Jul 2021 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: Chief Scientific Officer
Signature: /s/ Jacob Vincent Micallef
Issuer symbol: VNRX
Transactions as of: 14 Jul 2021
Net transactions value: $0
Form type: 4
Filing time: 16 Jul 2021, 16:55:37 UTC
Next filing: 23 Sep 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VNRX	Stock Option (Right to Buy)	Disposed to Issuer		-55,000	-100%		0	14 Jul 2021	Common Stock	55,000	$4.00	Direct	F1
transaction	VNRX	Stock Option (Right to Buy)	Award		+55,000			55,000	14 Jul 2021	Common Stock	55,000	$4.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old' options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant).

Content

The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old' options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant).